Strides Pharma Asia has agreed to purchase a 55% stake in South African pharmaceutical company Trinity Pharma for R55m ($4.31m).

Following the acquisition, Trinity Pharma’s management will continue as minority partner, running the business under the supervision of Strides Pharma Asia.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

“GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia.”

Strides Pharma Asia is a Singaporean pharmaceutical company and a subsidiary of Strides Shasun. The acquisition will enable the company to establish its presence in South Africa.

GlaxoSmithKline (GSK) has purchased an additional 26% stake in Glaxo Saudi Arabia (GSAL) increasing its total stake to 75%.

The acquisition will enable the UK-based pharmaceutical company to expand its presence in Saudi Arabia.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Have you nominated?

Nominations are now open for the prestigious Pharmaceutical Technology Excellence Awards - one of the industry's most recognised programmes celebrating innovation, leadership, and impact. This is your chance to showcase your achievements, highlight industry advancements, and gain global recognition. Don't miss the opportunity to be honoured among the best - submit your nomination today!

Nominate Now